Amylyx Pharmaceuticals To Host Conference Call To Discuss The Acquisition Of Avexitide On Wednesday, July 10, 2024, at 8:00 a.m. ET; No Terms Disclosed In Press Release
Author: Benzinga Newsdesk | July 09, 2024 04:33pm
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced that Amylyx' management team will host a conference call and webcast tomorrow, Wednesday, July 10, 2024, at 8:00 a.m. ET to discuss the acquisition of avexitide from Eiger BioPharmaceuticals.
Posted In: AMLX